Evaluation of the Labcorp COVID-19+Flu+RSV Test Home Collection Kit

COVID-19 Respiratory Infection Clinical Trial

Official title: Prospective Clinical Evaluation of the Labcorp COVID-19+Flu+RSV Test Home Collection Kit as Offered Commercially by Labcorp - A Registry Study

Status Recruiting

Clinical Trial Summary

To compare the results obtained by analysis of a self-collected anterior nasal (AN) swab as part of the Labcorp COVID-19+Flu+RSV Test Home Collection Kit to a healthcare provider (HCP)-collected AN swab in patients with symptoms of viral respiratory infection consistent with influenza A (Flu A), influenza B (Flu B), respiratory syncytial virus (RSV) and/or SARS-CoV-2 (C-19).

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Communicable Diseases
• COVID-19
• Infections
• Influenza A
• Influenza Type B
• Influenza, Human
• Respiratory Syncytial Virus Infections
• Respiratory Tract Infections
• RSV Infection

• NCT number: NCT06008457
• Study type: Observational [Patient Registry]
• Source: Sequenom, Inc.
• Contact: Graham McLennan, MS
• Phone: 858 202-9162
• Email: mclenng@labcorp.com
• Status: Recruiting
• Start date: April 17, 2023
• Completion date: May 17, 2024